Prometheus Phase II Data For Novel TL1A Inhibitor Impresses On Efficacy

 
• By Jessica Merrill
Bullseye
Prometheus hit the mark on a key Phase II trial • Source: Shutterstock

More from Clinical Trials

More from R&D